+1 #(S1 (S (ADVP (RB Here)) (NP (PRP we)) (VP (VP (VBP demonstrate) (NP (NN colocalization))) (CC and) (VP (VBP direct) (NP (NP (NN interaction)) (PP (IN between) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_)))))))))
+1 #(S1 (S (NP (NP (NN Overexpression)) (PP (IN of) (NP (NN _PROT1_)))) (VP (VBZ results) (PP (IN in) (NP (NP (NP (DT a) (NN zinc) (JJ finger-dependent) (NN localization)) (PP (IN of) (NP (DT a) (NN _PROT2_) (NN isoform)))) (CC and) (NP (NP (NN dynactin)) (PP (TO to) (NP (NN MT) (NNS bundles)))))) (, ,) (S (VP (VBG raising) (NP (DT the) (NN possibility) (SBAR (IN that) (S (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))) (VP (VBP regulate) (NP (NP (NN dynein/dynactin) (NN binding)) (PP (TO to) (NP (NNS MTs)))))))))))))
-1 #(S1 (S (NP (NP (NN Overexpression)) (PP (IN of) (NP (NN _PROT1_)))) (VP (VBZ results) (PP (IN in) (NP (NP (NP (DT a) (NN zinc) (JJ finger-dependent) (NN localization)) (PP (IN of) (NP (DT a) (NN _PROT_) (NN isoform)))) (CC and) (NP (NP (NN dynactin)) (PP (TO to) (NP (NN MT) (NNS bundles)))))) (, ,) (S (VP (VBG raising) (NP (DT the) (NN possibility) (SBAR (IN that) (S (NP (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_))) (VP (VBP regulate) (NP (NP (NN dynein/dynactin) (NN binding)) (PP (TO to) (NP (NNS MTs)))))))))))))
-1 #(S1 (S (NP (NP (NN Overexpression)) (PP (IN of) (NP (NN _PROT1_)))) (VP (VBZ results) (PP (IN in) (NP (NP (NP (DT a) (NN zinc) (JJ finger-dependent) (NN localization)) (PP (IN of) (NP (DT a) (NN _PROT_) (NN isoform)))) (CC and) (NP (NP (NN dynactin)) (PP (TO to) (NP (NN MT) (NNS bundles)))))) (, ,) (S (VP (VBG raising) (NP (DT the) (NN possibility) (SBAR (IN that) (S (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_))) (VP (VBP regulate) (NP (NP (NN dynein/dynactin) (NN binding)) (PP (TO to) (NP (NNS MTs)))))))))))))
-1 #(S1 (S (NP (NP (NN Overexpression)) (PP (IN of) (NP (NN _PROT_)))) (VP (VBZ results) (PP (IN in) (NP (NP (NP (DT a) (NN zinc) (JJ finger-dependent) (NN localization)) (PP (IN of) (NP (DT a) (NN _PROT1_) (NN isoform)))) (CC and) (NP (NP (NN dynactin)) (PP (TO to) (NP (NN MT) (NNS bundles)))))) (, ,) (S (VP (VBG raising) (NP (DT the) (NN possibility) (SBAR (IN that) (S (NP (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_))) (VP (VBP regulate) (NP (NP (NN dynein/dynactin) (NN binding)) (PP (TO to) (NP (NNS MTs)))))))))))))
-1 #(S1 (S (NP (NP (NN Overexpression)) (PP (IN of) (NP (NN _PROT_)))) (VP (VBZ results) (PP (IN in) (NP (NP (NP (DT a) (NN zinc) (JJ finger-dependent) (NN localization)) (PP (IN of) (NP (DT a) (NN _PROT1_) (NN isoform)))) (CC and) (NP (NP (NN dynactin)) (PP (TO to) (NP (NN MT) (NNS bundles)))))) (, ,) (S (VP (VBG raising) (NP (DT the) (NN possibility) (SBAR (IN that) (S (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_))) (VP (VBP regulate) (NP (NP (NN dynein/dynactin) (NN binding)) (PP (TO to) (NP (NNS MTs)))))))))))))
-1 #(S1 (S (NP (NP (NN Overexpression)) (PP (IN of) (NP (NN _PROT_)))) (VP (VBZ results) (PP (IN in) (NP (NP (NP (DT a) (NN zinc) (JJ finger-dependent) (NN localization)) (PP (IN of) (NP (DT a) (NN _PROT_) (NN isoform)))) (CC and) (NP (NP (NN dynactin)) (PP (TO to) (NP (NN MT) (NNS bundles)))))) (, ,) (S (VP (VBG raising) (NP (DT the) (NN possibility) (SBAR (IN that) (S (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))) (VP (VBP regulate) (NP (NP (NN dynein/dynactin) (NN binding)) (PP (TO to) (NP (NNS MTs)))))))))))))
+1 #(S1 (S (NP (DT This) (NN work)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBZ is) (NP (NP (DT a) (JJ regulated) (NN adapter)) (PP (IN between) (NP (NP (NN _PROT2_)) (CC and) (NP (JJ cytoplasmic) (NN dynein)))) (PP (PP (IN at) (NP (NP (NNS sites)) (VP (VBN involved) (PP (IN in) (NP (NN cargo-MT) (NN loading)))))) (, ,) (CC and/or) (PP (IN in) (NP (NP (DT the) (NN control)) (PP (IN of) (NP (NN MT) (NNS dynamics)))))))))))))
-1 #(S1 (S (NP (NP (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN type) (NN II) (NN isozyme)) (-RRB- -RRB-))) (VP (VBZ contains) (NP (NP (NP (DT a) (NN _PROT2_) (NN homology) (NN domain)) (PP (IN at) (NP (DT the) (NN N) (NN terminus)))) (CC and) (NP (NP (DT a) (JJ sterile) (NN alpha) (NN motif) (NN domain)) (PP (IN at) (NP (DT the) (NN C) (NN terminus))))))))
-1 #(S1 (S (NP (NP (JJ Differential) (NN binding)) (PP (IN of) (NP (NP (JJ vascular) (JJ cell-derived) (NNS proteoglycans)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT2_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_))) (-RRB- -RRB-)))) (PP (TO to) (NP (NP (DT the) (NN beta-amyloid) (NN protein)) (PP (IN of) (NP (NN Alzheimer) (POS 's) (NN disease))))))))
-1 #(S1 (S (NP (NP (JJ Differential) (NN binding)) (PP (IN of) (NP (NP (JJ vascular) (JJ cell-derived) (NNS proteoglycans)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT2_)) (, ,) (CC and) (NP (NN _PROT_))) (-RRB- -RRB-)))) (PP (TO to) (NP (NP (DT the) (NN beta-amyloid) (NN protein)) (PP (IN of) (NP (NN Alzheimer) (POS 's) (NN disease))))))))
-1 #(S1 (S (NP (NP (JJ Differential) (NN binding)) (PP (IN of) (NP (NP (JJ vascular) (JJ cell-derived) (NNS proteoglycans)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT2_))) (-RRB- -RRB-)))) (PP (TO to) (NP (NP (DT the) (NN beta-amyloid) (NN protein)) (PP (IN of) (NP (NN Alzheimer) (POS 's) (NN disease))))))))
-1 #(S1 (S (NP (NP (JJ Differential) (NN binding)) (PP (IN of) (NP (NP (JJ vascular) (JJ cell-derived) (NNS proteoglycans)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_)) (, ,) (NP (NN _PROT2_)) (, ,) (CC and) (NP (NN _PROT_))) (-RRB- -RRB-)))) (PP (TO to) (NP (NP (DT the) (NN beta-amyloid) (NN protein)) (PP (IN of) (NP (NN Alzheimer) (POS 's) (NN disease))))))))
-1 #(S1 (S (NP (NP (JJ Differential) (NN binding)) (PP (IN of) (NP (NP (JJ vascular) (JJ cell-derived) (NNS proteoglycans)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT2_))) (-RRB- -RRB-)))) (PP (TO to) (NP (NP (DT the) (NN beta-amyloid) (NN protein)) (PP (IN of) (NP (NN Alzheimer) (POS 's) (NN disease))))))))
-1 #(S1 (S (NP (NP (JJ Differential) (NN binding)) (PP (IN of) (NP (NP (JJ vascular) (JJ cell-derived) (NNS proteoglycans)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_)) (, ,) (CC and) (NP (NN _PROT2_))) (-RRB- -RRB-)))) (PP (TO to) (NP (NP (DT the) (NN beta-amyloid) (NN protein)) (PP (IN of) (NP (NN Alzheimer) (POS 's) (NN disease))))))))
-1 #(S1 (S (NP (JJ Previous) (NNS studies)) (VP (VBP have) (VP (VBN demonstrated) (NP (NP (DT the) (NN immunolocalization)) (PP (IN of) (NP (NP (NN _PROT1_)) (, ,) (NP (DT a) (JJ specific) (NN _PROT2_) (NN _PROT2_) (NN _PROT2_)) (, ,))) (PP (TO to) (NP (NP (DT the) (NN _PROT_) (NN protein) (PRN (-LRB- -LRB-) (NP (NN A) (NN beta)) (-RRB- -RRB-)) (JJ -containing) (NN _PROT_) (NNS deposits)) (PP (IN within) (NP (NP (DT the) (NNS walls)) (PP (IN of) (NP (NP (NN blood) (NNS vessels)) (PRN (-LRB- -LRB-) (PP (FW i.e.) (, ,) (NP (JJ congophilic) (NN angiopathy))) (-RRB- -RRB-)))))) (PP (IN in) (NP (NP (NP (NN Alzheimer) (POS 's) (NN disease)) (PRN (-LRB- -LRB-) (NP (NN AD)) (-RRB- -RRB-))) (NN brain))))))))))
+1 #(S1 (S (NP (JJ Previous) (NNS studies)) (VP (VBP have) (VP (VBN demonstrated) (NP (NP (DT the) (NN immunolocalization)) (PP (IN of) (NP (NP (NN _PROT1_)) (, ,) (NP (DT a) (JJ specific) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (, ,))) (PP (TO to) (NP (NP (DT the) (NN _PROT2_) (NN protein) (PRN (-LRB- -LRB-) (NP (NN A) (NN beta)) (-RRB- -RRB-)) (JJ -containing) (NN _PROT_) (NNS deposits)) (PP (IN within) (NP (NP (DT the) (NNS walls)) (PP (IN of) (NP (NP (NN blood) (NNS vessels)) (PRN (-LRB- -LRB-) (PP (FW i.e.) (, ,) (NP (JJ congophilic) (NN angiopathy))) (-RRB- -RRB-)))))) (PP (IN in) (NP (NP (NP (NN Alzheimer) (POS 's) (NN disease)) (PRN (-LRB- -LRB-) (NP (NN AD)) (-RRB- -RRB-))) (NN brain))))))))))
+1 #(S1 (S (NP (JJ Previous) (NNS studies)) (VP (VBP have) (VP (VBN demonstrated) (NP (NP (DT the) (NN immunolocalization)) (PP (IN of) (NP (NP (NN _PROT1_)) (, ,) (NP (DT a) (JJ specific) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (, ,))) (PP (TO to) (NP (NP (DT the) (NN _PROT_) (NN protein) (PRN (-LRB- -LRB-) (NP (NN A) (NN beta)) (-RRB- -RRB-)) (JJ -containing) (NN _PROT2_) (NNS deposits)) (PP (IN within) (NP (NP (DT the) (NNS walls)) (PP (IN of) (NP (NP (NN blood) (NNS vessels)) (PRN (-LRB- -LRB-) (PP (FW i.e.) (, ,) (NP (JJ congophilic) (NN angiopathy))) (-RRB- -RRB-)))))) (PP (IN in) (NP (NP (NP (NN Alzheimer) (POS 's) (NN disease)) (PRN (-LRB- -LRB-) (NP (NN AD)) (-RRB- -RRB-))) (NN brain))))))))))
+1 #(S1 (S (NP (JJ Previous) (NNS studies)) (VP (VBP have) (VP (VBN demonstrated) (NP (NP (DT the) (NN immunolocalization)) (PP (IN of) (NP (NP (NN _PROT_)) (, ,) (NP (DT a) (JJ specific) (NN _PROT1_) (NN _PROT1_) (NN _PROT1_)) (, ,))) (PP (TO to) (NP (NP (DT the) (NN _PROT2_) (NN protein) (PRN (-LRB- -LRB-) (NP (NN A) (NN beta)) (-RRB- -RRB-)) (JJ -containing) (NN _PROT_) (NNS deposits)) (PP (IN within) (NP (NP (DT the) (NNS walls)) (PP (IN of) (NP (NP (NN blood) (NNS vessels)) (PRN (-LRB- -LRB-) (PP (FW i.e.) (, ,) (NP (JJ congophilic) (NN angiopathy))) (-RRB- -RRB-)))))) (PP (IN in) (NP (NP (NP (NN Alzheimer) (POS 's) (NN disease)) (PRN (-LRB- -LRB-) (NP (NN AD)) (-RRB- -RRB-))) (NN brain))))))))))
+1 #(S1 (S (NP (JJ Previous) (NNS studies)) (VP (VBP have) (VP (VBN demonstrated) (NP (NP (DT the) (NN immunolocalization)) (PP (IN of) (NP (NP (NN _PROT_)) (, ,) (NP (DT a) (JJ specific) (NN _PROT1_) (NN _PROT1_) (NN _PROT1_)) (, ,))) (PP (TO to) (NP (NP (DT the) (NN _PROT_) (NN protein) (PRN (-LRB- -LRB-) (NP (NN A) (NN beta)) (-RRB- -RRB-)) (JJ -containing) (NN _PROT2_) (NNS deposits)) (PP (IN within) (NP (NP (DT the) (NNS walls)) (PP (IN of) (NP (NP (NN blood) (NNS vessels)) (PRN (-LRB- -LRB-) (PP (FW i.e.) (, ,) (NP (JJ congophilic) (NN angiopathy))) (-RRB- -RRB-)))))) (PP (IN in) (NP (NP (NP (NN Alzheimer) (POS 's) (NN disease)) (PRN (-LRB- -LRB-) (NP (NN AD)) (-RRB- -RRB-))) (NN brain))))))))))
-1 #(S1 (S (NP (JJ Previous) (NNS studies)) (VP (VBP have) (VP (VBN demonstrated) (NP (NP (DT the) (NN immunolocalization)) (PP (IN of) (NP (NP (NN _PROT_)) (, ,) (NP (DT a) (JJ specific) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (, ,))) (PP (TO to) (NP (NP (DT the) (NN _PROT1_) (NN protein) (PRN (-LRB- -LRB-) (NP (NN A) (NN beta)) (-RRB- -RRB-)) (JJ -containing) (NN _PROT2_) (NNS deposits)) (PP (IN within) (NP (NP (DT the) (NNS walls)) (PP (IN of) (NP (NP (NN blood) (NNS vessels)) (PRN (-LRB- -LRB-) (PP (FW i.e.) (, ,) (NP (JJ congophilic) (NN angiopathy))) (-RRB- -RRB-)))))) (PP (IN in) (NP (NP (NP (NN Alzheimer) (POS 's) (NN disease)) (PRN (-LRB- -LRB-) (NP (NN AD)) (-RRB- -RRB-))) (NN brain))))))))))
-1 #(S1 (S (ADVP (RB Overall)) (, ,) (NP (DT the) (NNS results)) (VP (VBP indicate) (SBAR (SBAR (IN that) (S (NP (JJ specific) (JJ vascular) (JJ cell-derived) (NNS _PROT1_)) (ADVP (RB differentially)) (VP (VBP interact) (PP (IN with) (NP (NN A) (NN beta)))))) (, ,) (CC and) (SBAR (IN that) (S (NP (NP (DT the) (NNS interactions)) (PP (IN of) (NP (JJS highest) (NN affinity)))) (VP (VBP occur) (PP (IN between) (NP (NP (NP (NN A) (NN beta)) (CC and) (NP (NN binding) (NNS sites))) (PP (IN on) (NP (CC both) (NP (DT the) (NN core) (NN protein)) (CC and) (NP (NP (NN glycosaminoglycan) (NNS chains)) (PP (IN of) (NP (NN _PROT2_)))))))))))))))
-1 #(S1 (S (PP (IN In) (NP (DT the) (JJ present) (NN investigation))) (, ,) (NP (NP (DT the) (JJ differential) (NN binding)) (PP (IN of) (NP (ADJP (RB previously) (VBN characterized)) (ADJP (NP (NP (JJ endothelial) (NN cell)) (PRN (-LRB- -LRB-) (NP (NN EC)) (-RRB- -RRB-)) (: -) (CC and) (NP (NP (JJ smooth) (NN muscle) (NN cell)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-)))) (JJ -derived)) (NNS _PROT2_))) (PP (TO to) (NP (NN A) (NN beta)))) (VP (VBD was) (VP (VBN examined) (S (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP (NP (DT the) (NN accumulation)) (PP (IN of) (NP (NN A) (NN beta))) (PP (IN in) (NP (JJ cerebrovascular) (NN _PROT_) (NNS deposits)))) (VP (MD may) (VP (VB be) (ADJP (JJ due) (PP (TO to) (NP (NP (PRP$ its) (NNS interactions)) (PP (IN with) (NP (NN _PROT_)))))))))))))))))
-1 #(S1 (S (PP (IN In) (NP (DT the) (JJ present) (NN investigation))) (, ,) (NP (NP (DT the) (JJ differential) (NN binding)) (PP (IN of) (NP (ADJP (RB previously) (VBN characterized)) (ADJP (NP (NP (JJ endothelial) (NN cell)) (PRN (-LRB- -LRB-) (NP (NN EC)) (-RRB- -RRB-)) (: -) (CC and) (NP (NP (JJ smooth) (NN muscle) (NN cell)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-)))) (JJ -derived)) (NNS _PROT_))) (PP (TO to) (NP (NN A) (NN beta)))) (VP (VBD was) (VP (VBN examined) (S (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP (NP (DT the) (NN accumulation)) (PP (IN of) (NP (NN A) (NN beta))) (PP (IN in) (NP (JJ cerebrovascular) (NN _PROT2_) (NNS deposits)))) (VP (MD may) (VP (VB be) (ADJP (JJ due) (PP (TO to) (NP (NP (PRP$ its) (NNS interactions)) (PP (IN with) (NP (NN _PROT_)))))))))))))))))
-1 #(S1 (S (PP (IN In) (NP (DT the) (JJ present) (NN investigation))) (, ,) (NP (NP (DT the) (JJ differential) (NN binding)) (PP (IN of) (NP (ADJP (RB previously) (VBN characterized)) (ADJP (NP (NP (JJ endothelial) (NN cell)) (PRN (-LRB- -LRB-) (NP (NN EC)) (-RRB- -RRB-)) (: -) (CC and) (NP (NP (JJ smooth) (NN muscle) (NN cell)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-)))) (JJ -derived)) (NNS _PROT_))) (PP (TO to) (NP (NN A) (NN beta)))) (VP (VBD was) (VP (VBN examined) (S (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP (NP (DT the) (NN accumulation)) (PP (IN of) (NP (NN A) (NN beta))) (PP (IN in) (NP (JJ cerebrovascular) (NN _PROT_) (NNS deposits)))) (VP (MD may) (VP (VB be) (ADJP (JJ due) (PP (TO to) (NP (NP (PRP$ its) (NNS interactions)) (PP (IN with) (NP (NN _PROT2_)))))))))))))))))
-1 #(S1 (S (PP (IN In) (NP (DT the) (JJ present) (NN investigation))) (, ,) (NP (NP (DT the) (JJ differential) (NN binding)) (PP (IN of) (NP (ADJP (RB previously) (VBN characterized)) (ADJP (NP (NP (JJ endothelial) (NN cell)) (PRN (-LRB- -LRB-) (NP (NN EC)) (-RRB- -RRB-)) (: -) (CC and) (NP (NP (JJ smooth) (NN muscle) (NN cell)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (JJ -derived)) (NNS _PROT1_))) (PP (TO to) (NP (NN A) (NN beta)))) (VP (VBD was) (VP (VBN examined) (S (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP (NP (DT the) (NN accumulation)) (PP (IN of) (NP (NN A) (NN beta))) (PP (IN in) (NP (JJ cerebrovascular) (NN _PROT2_) (NNS deposits)))) (VP (MD may) (VP (VB be) (ADJP (JJ due) (PP (TO to) (NP (NP (PRP$ its) (NNS interactions)) (PP (IN with) (NP (NN _PROT_)))))))))))))))))
-1 #(S1 (S (PP (IN In) (NP (DT the) (JJ present) (NN investigation))) (, ,) (NP (NP (DT the) (JJ differential) (NN binding)) (PP (IN of) (NP (ADJP (RB previously) (VBN characterized)) (ADJP (NP (NP (JJ endothelial) (NN cell)) (PRN (-LRB- -LRB-) (NP (NN EC)) (-RRB- -RRB-)) (: -) (CC and) (NP (NP (JJ smooth) (NN muscle) (NN cell)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (JJ -derived)) (NNS _PROT1_))) (PP (TO to) (NP (NN A) (NN beta)))) (VP (VBD was) (VP (VBN examined) (S (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP (NP (DT the) (NN accumulation)) (PP (IN of) (NP (NN A) (NN beta))) (PP (IN in) (NP (JJ cerebrovascular) (NN _PROT_) (NNS deposits)))) (VP (MD may) (VP (VB be) (ADJP (JJ due) (PP (TO to) (NP (NP (PRP$ its) (NNS interactions)) (PP (IN with) (NP (NN _PROT2_)))))))))))))))))
-1 #(S1 (S (PP (IN In) (NP (DT the) (JJ present) (NN investigation))) (, ,) (NP (NP (DT the) (JJ differential) (NN binding)) (PP (IN of) (NP (ADJP (RB previously) (VBN characterized)) (ADJP (NP (NP (JJ endothelial) (NN cell)) (PRN (-LRB- -LRB-) (NP (NN EC)) (-RRB- -RRB-)) (: -) (CC and) (NP (NP (JJ smooth) (NN muscle) (NN cell)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (JJ -derived)) (NNS _PROT_))) (PP (TO to) (NP (NN A) (NN beta)))) (VP (VBD was) (VP (VBN examined) (S (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP (NP (DT the) (NN accumulation)) (PP (IN of) (NP (NN A) (NN beta))) (PP (IN in) (NP (JJ cerebrovascular) (NN _PROT1_) (NNS deposits)))) (VP (MD may) (VP (VB be) (ADJP (JJ due) (PP (TO to) (NP (NP (PRP$ its) (NNS interactions)) (PP (IN with) (NP (NN _PROT2_)))))))))))))))))
-1 #(S1 (S (NP (NP (NN Pretreatment)) (PP (IN of) (NP (NN AA) (JJ amyloidotic) (UCP (ADJP (JJ splenic)) (CC and) (NP (NN liver))) (NN tissue) (NNS sections))) (PP (IN with) (NP (NP (JJ synthetic) (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-))))) (VP (VBD produced) (NP (JJ strong) (NN immunoreactivity)) (PP (IN with) (NP (NN A) (NN beta) (NNS antibodies))) (PP (IN at) (NP (NP (NN tissue) (NNS sites)) (VP (VBN enriched) (PP (IN in) (NP (NP (NN _PROT1_)) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (ADVP (RB partially)) (VP (VBN removed) (PP (PP (IN by) (NP (NP (NN pretreatment)) (PP (IN with) (NP (NN heparitinase))))) (, ,) (CC but) (PP (RB not) (IN by) (NP (NN chondroitin) (NN _PROT2_) (NN lyase))))))))))))))))
-1 #(S1 (S (NP (NP (LST (LS [35S) (-RRB- -RSB-)) (NP (JJ -Sulfate) (JJ labeled) (NNS proteoglycans)) (PRN (-LRB- -LRB-) (NP (NNS _PROT1_)) (-RRB- -RRB-)) (VP (VBN derived) (PP (IN from) (NP (VBN cultured) (NP (NNS ECs)) (CC and) (NP (NNS SMCs)))))) (VP (VBD bound) (PP (TO to) (NP (NP (NN affinity) (NNS columns)) (VP (VBG containing) (NP (NP (DT A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)) (CC or) (PRN (-LRB- -LRB-) (NP (NN 1-40)) (-RRB- -RRB-)))))) (, ,) (PP (IN with) (NP (NP (ADJP (RB virtually) (DT no)) (NN binding)) (PP (TO to) (NP (NP (NP (NP (DT A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 40-1)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NN reverse) (NN peptide)) (-RRB- -RRB-))) (, ,) (NP (NP (NN beta-amyloid) (NN precursor) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN 410-429)) (-RRB- -RRB-))) (, ,) (CC or) (NP (JJ bovine) (NN _PROT2_) (NN _PROT2_))))))))))
-1 #(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NP (NN EC)) (CC and) (NP (NN _PROT1_))) (NNS _PROT2_)) (VP (VBN bound) (PP (TO to) (NP (NP (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)))))))) (VP (VBD revealed) (NP (NP (NP (JJ strong) (NN binding)) (PP (IN by) (NP (NN _PROT_)))) (, ,) (NP (NP (JJ weak) (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))) (, ,) (NP (CD two) (NN dermatan) (NN sulfate) (NNS proteoglycans)) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (, ,) (NP (DT a) (JJ large) (NN chondroitin) (NN sulfate) (NN proteoglycan)))))))))))
-1 #(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NP (NN EC)) (CC and) (NP (NN _PROT1_))) (NNS _PROT_)) (VP (VBN bound) (PP (TO to) (NP (NP (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)))))))) (VP (VBD revealed) (NP (NP (NP (JJ strong) (NN binding)) (PP (IN by) (NP (NN _PROT2_)))) (, ,) (NP (NP (JJ weak) (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))) (, ,) (NP (CD two) (NN dermatan) (NN sulfate) (NNS proteoglycans)) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (, ,) (NP (DT a) (JJ large) (NN chondroitin) (NN sulfate) (NN proteoglycan)))))))))))
-1 #(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NP (NN EC)) (CC and) (NP (NN _PROT1_))) (NNS _PROT_)) (VP (VBN bound) (PP (TO to) (NP (NP (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)))))))) (VP (VBD revealed) (NP (NP (NP (JJ strong) (NN binding)) (PP (IN by) (NP (NN _PROT_)))) (, ,) (NP (NP (JJ weak) (NN binding)) (PP (IN by) (NP (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_))))) (, ,) (NP (CD two) (NN dermatan) (NN sulfate) (NNS proteoglycans)) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (, ,) (NP (DT a) (JJ large) (NN chondroitin) (NN sulfate) (NN proteoglycan)))))))))))
-1 #(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NP (NN EC)) (CC and) (NP (NN _PROT1_))) (NNS _PROT_)) (VP (VBN bound) (PP (TO to) (NP (NP (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)))))))) (VP (VBD revealed) (NP (NP (NP (JJ strong) (NN binding)) (PP (IN by) (NP (NN _PROT_)))) (, ,) (NP (NP (JJ weak) (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_))))) (, ,) (NP (CD two) (NN dermatan) (NN sulfate) (NNS proteoglycans)) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (, ,) (NP (DT a) (JJ large) (NN chondroitin) (NN sulfate) (NN proteoglycan)))))))))))
-1 #(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NP (NN EC)) (CC and) (NP (NN _PROT1_))) (NNS _PROT_)) (VP (VBN bound) (PP (TO to) (NP (NP (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)))))))) (VP (VBD revealed) (NP (NP (NP (JJ strong) (NN binding)) (PP (IN by) (NP (NN _PROT_)))) (, ,) (NP (NP (JJ weak) (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))) (, ,) (NP (CD two) (NN dermatan) (NN sulfate) (NNS proteoglycans)) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN binding)) (PP (IN by) (NP (NP (NN _PROT2_)) (, ,) (NP (DT a) (JJ large) (NN chondroitin) (NN sulfate) (NN proteoglycan)))))))))))
-1 #(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NP (NN EC)) (CC and) (NP (NN _PROT1_))) (NNS _PROT_)) (VP (VBN bound) (PP (TO to) (NP (NP (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)))))))) (VP (VBD revealed) (NP (NP (NP (JJ strong) (NN binding)) (PP (IN by) (NP (NN _PROT_)))) (, ,) (NP (NP (JJ weak) (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))) (, ,) (NP (CD two) (NN dermatan) (NN sulfate) (NNS proteoglycans)) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN binding)) (PP (IN by) (NP (NP (NN _PROT2_)) (, ,) (NP (DT a) (JJ large) (NN chondroitin) (NN sulfate) (NN proteoglycan)))))))))))
+1 #(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NP (NN EC)) (CC and) (NP (NN _PROT_))) (NNS _PROT1_)) (VP (VBN bound) (PP (TO to) (NP (NP (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)))))))) (VP (VBD revealed) (NP (NP (NP (JJ strong) (NN binding)) (PP (IN by) (NP (NN _PROT2_)))) (, ,) (NP (NP (JJ weak) (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))) (, ,) (NP (CD two) (NN dermatan) (NN sulfate) (NNS proteoglycans)) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (, ,) (NP (DT a) (JJ large) (NN chondroitin) (NN sulfate) (NN proteoglycan)))))))))))
+1 #(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NP (NN EC)) (CC and) (NP (NN _PROT_))) (NNS _PROT1_)) (VP (VBN bound) (PP (TO to) (NP (NP (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)))))))) (VP (VBD revealed) (NP (NP (NP (JJ strong) (NN binding)) (PP (IN by) (NP (NN _PROT_)))) (, ,) (NP (NP (JJ weak) (NN binding)) (PP (IN by) (NP (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_))))) (, ,) (NP (CD two) (NN dermatan) (NN sulfate) (NNS proteoglycans)) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (, ,) (NP (DT a) (JJ large) (NN chondroitin) (NN sulfate) (NN proteoglycan)))))))))))
+1 #(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NP (NN EC)) (CC and) (NP (NN _PROT_))) (NNS _PROT1_)) (VP (VBN bound) (PP (TO to) (NP (NP (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)))))))) (VP (VBD revealed) (NP (NP (NP (JJ strong) (NN binding)) (PP (IN by) (NP (NN _PROT_)))) (, ,) (NP (NP (JJ weak) (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_))))) (, ,) (NP (CD two) (NN dermatan) (NN sulfate) (NNS proteoglycans)) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (, ,) (NP (DT a) (JJ large) (NN chondroitin) (NN sulfate) (NN proteoglycan)))))))))))
-1 #(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NP (NN EC)) (CC and) (NP (NN _PROT_))) (NNS _PROT1_)) (VP (VBN bound) (PP (TO to) (NP (NP (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)))))))) (VP (VBD revealed) (NP (NP (NP (JJ strong) (NN binding)) (PP (IN by) (NP (NN _PROT_)))) (, ,) (NP (NP (JJ weak) (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))) (, ,) (NP (CD two) (NN dermatan) (NN sulfate) (NNS proteoglycans)) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN binding)) (PP (IN by) (NP (NP (NN _PROT2_)) (, ,) (NP (DT a) (JJ large) (NN chondroitin) (NN sulfate) (NN proteoglycan)))))))))))
-1 #(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NP (NN EC)) (CC and) (NP (NN _PROT_))) (NNS _PROT1_)) (VP (VBN bound) (PP (TO to) (NP (NP (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)))))))) (VP (VBD revealed) (NP (NP (NP (JJ strong) (NN binding)) (PP (IN by) (NP (NN _PROT_)))) (, ,) (NP (NP (JJ weak) (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))) (, ,) (NP (CD two) (NN dermatan) (NN sulfate) (NNS proteoglycans)) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN binding)) (PP (IN by) (NP (NP (NN _PROT2_)) (, ,) (NP (DT a) (JJ large) (NN chondroitin) (NN sulfate) (NN proteoglycan)))))))))))
-1 #(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NP (NN EC)) (CC and) (NP (NN _PROT_))) (NNS _PROT_)) (VP (VBN bound) (PP (TO to) (NP (NP (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)))))))) (VP (VBD revealed) (NP (NP (NP (JJ strong) (NN binding)) (PP (IN by) (NP (NN _PROT1_)))) (, ,) (NP (NP (JJ weak) (NN binding)) (PP (IN by) (NP (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_))))) (, ,) (NP (CD two) (NN dermatan) (NN sulfate) (NNS proteoglycans)) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (, ,) (NP (DT a) (JJ large) (NN chondroitin) (NN sulfate) (NN proteoglycan)))))))))))
-1 #(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NP (NN EC)) (CC and) (NP (NN _PROT_))) (NNS _PROT_)) (VP (VBN bound) (PP (TO to) (NP (NP (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)))))))) (VP (VBD revealed) (NP (NP (NP (JJ strong) (NN binding)) (PP (IN by) (NP (NN _PROT1_)))) (, ,) (NP (NP (JJ weak) (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_))))) (, ,) (NP (CD two) (NN dermatan) (NN sulfate) (NNS proteoglycans)) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (, ,) (NP (DT a) (JJ large) (NN chondroitin) (NN sulfate) (NN proteoglycan)))))))))))
-1 #(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NP (NN EC)) (CC and) (NP (NN _PROT_))) (NNS _PROT_)) (VP (VBN bound) (PP (TO to) (NP (NP (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)))))))) (VP (VBD revealed) (NP (NP (NP (JJ strong) (NN binding)) (PP (IN by) (NP (NN _PROT1_)))) (, ,) (NP (NP (JJ weak) (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))) (, ,) (NP (CD two) (NN dermatan) (NN sulfate) (NNS proteoglycans)) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN binding)) (PP (IN by) (NP (NP (NN _PROT2_)) (, ,) (NP (DT a) (JJ large) (NN chondroitin) (NN sulfate) (NN proteoglycan)))))))))))
-1 #(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NP (NN EC)) (CC and) (NP (NN _PROT_))) (NNS _PROT_)) (VP (VBN bound) (PP (TO to) (NP (NP (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)))))))) (VP (VBD revealed) (NP (NP (NP (JJ strong) (NN binding)) (PP (IN by) (NP (NN _PROT1_)))) (, ,) (NP (NP (JJ weak) (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))) (, ,) (NP (CD two) (NN dermatan) (NN sulfate) (NNS proteoglycans)) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN binding)) (PP (IN by) (NP (NP (NN _PROT2_)) (, ,) (NP (DT a) (JJ large) (NN chondroitin) (NN sulfate) (NN proteoglycan)))))))))))
-1 #(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NP (NN EC)) (CC and) (NP (NN _PROT_))) (NNS _PROT_)) (VP (VBN bound) (PP (TO to) (NP (NP (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)))))))) (VP (VBD revealed) (NP (NP (NP (JJ strong) (NN binding)) (PP (IN by) (NP (NN _PROT_)))) (, ,) (NP (NP (JJ weak) (NN binding)) (PP (IN by) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))))) (, ,) (NP (CD two) (NN dermatan) (NN sulfate) (NNS proteoglycans)) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (, ,) (NP (DT a) (JJ large) (NN chondroitin) (NN sulfate) (NN proteoglycan)))))))))))
-1 #(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NP (NN EC)) (CC and) (NP (NN _PROT_))) (NNS _PROT_)) (VP (VBN bound) (PP (TO to) (NP (NP (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)))))))) (VP (VBD revealed) (NP (NP (NP (JJ strong) (NN binding)) (PP (IN by) (NP (NN _PROT_)))) (, ,) (NP (NP (JJ weak) (NN binding)) (PP (IN by) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))))) (, ,) (NP (CD two) (NN dermatan) (NN sulfate) (NNS proteoglycans)) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN binding)) (PP (IN by) (NP (NP (NN _PROT2_)) (, ,) (NP (DT a) (JJ large) (NN chondroitin) (NN sulfate) (NN proteoglycan)))))))))))
-1 #(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NP (NN EC)) (CC and) (NP (NN _PROT_))) (NNS _PROT_)) (VP (VBN bound) (PP (TO to) (NP (NP (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)))))))) (VP (VBD revealed) (NP (NP (NP (JJ strong) (NN binding)) (PP (IN by) (NP (NN _PROT_)))) (, ,) (NP (NP (JJ weak) (NN binding)) (PP (IN by) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))))) (, ,) (NP (CD two) (NN dermatan) (NN sulfate) (NNS proteoglycans)) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN binding)) (PP (IN by) (NP (NP (NN _PROT2_)) (, ,) (NP (DT a) (JJ large) (NN chondroitin) (NN sulfate) (NN proteoglycan)))))))))))
-1 #(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NP (NN EC)) (CC and) (NP (NN _PROT_))) (NNS _PROT_)) (VP (VBN bound) (PP (TO to) (NP (NP (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)))))))) (VP (VBD revealed) (NP (NP (NP (JJ strong) (NN binding)) (PP (IN by) (NP (NN _PROT_)))) (, ,) (NP (NP (JJ weak) (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))))) (, ,) (NP (CD two) (NN dermatan) (NN sulfate) (NNS proteoglycans)) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN binding)) (PP (IN by) (NP (NP (NN _PROT2_)) (, ,) (NP (DT a) (JJ large) (NN chondroitin) (NN sulfate) (NN proteoglycan)))))))))))
-1 #(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NP (NN EC)) (CC and) (NP (NN _PROT_))) (NNS _PROT_)) (VP (VBN bound) (PP (TO to) (NP (NP (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)))))))) (VP (VBD revealed) (NP (NP (NP (JJ strong) (NN binding)) (PP (IN by) (NP (NN _PROT_)))) (, ,) (NP (NP (JJ weak) (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))))) (, ,) (NP (CD two) (NN dermatan) (NN sulfate) (NNS proteoglycans)) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN binding)) (PP (IN by) (NP (NP (NN _PROT2_)) (, ,) (NP (DT a) (JJ large) (NN chondroitin) (NN sulfate) (NN proteoglycan)))))))))))
-1 #(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NP (NN EC)) (CC and) (NP (NN _PROT_))) (NNS _PROT_)) (VP (VBN bound) (PP (TO to) (NP (NP (NN A) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN 1-28)) (-RRB- -RRB-)))))))) (VP (VBD revealed) (NP (NP (NP (JJ strong) (NN binding)) (PP (IN by) (NP (NN _PROT_)))) (, ,) (NP (NP (JJ weak) (NN binding)) (PP (IN by) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))) (, ,) (NP (CD two) (NN dermatan) (NN sulfate) (NNS proteoglycans)) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN binding)) (PP (IN by) (NP (NP (NN _PROT1_AND_PROT2_)) (, ,) (NP (DT a) (JJ large) (NN chondroitin) (NN sulfate) (NN proteoglycan)))))))))))
-1 #(S1 (S (ADVP (RB Herein)) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (DT a) (JJ distinct) (NN IkappaB) (NN protein) (NN _PROT1_)) (ADVP (RB also)) (VP (VBZ interacts) (PP (IN with) (NP (NN RXR))) (, ,) (SBAR (IN as) (S (VP (VBN shown) (PP (IN in) (NP (NP (DT the) (NN yeast) (JJ two-hybrid) (NNS tests)) (CC and) (NP (NP (NN _PROT2_) (NN _PROT2_)) (JJ pull-down) (NNS assays)))))))))))))
-1 #(S1 (S (PP (IN In) (NP (NP (NN contrast)) (PP (TO to) (NP (NN _PROT1_))))) (, ,) (NP (NN _PROT2_)) (VP (VBD did) (RB not) (VP (VB interact) (PP (IN with) (NP (NP (DT the) (NN AF2) (NN domain)) (PP (IN of) (NP (NN RXR)))))))))
+1 #(S1 (S (NP (NN _PROT1_)) (ADVP (RB specifically)) (VP (VBD interacted) (PP (PP (IN with) (NP (DT the) (JJ general) (NN transcription) (NNS factors) (NP (NP (NN _PROT2_)) (, ,) (NP (NN TBP)) (, ,) (CC and) (NP (NN _PROT_))))) (CC but) (PP (RB not) (IN with) (NP (NN TFIIEalpha)))) (PP (IN in) (NP (DT the) (NN _PROT_) (JJ pull-down) (NNS assays))))))
+1 #(S1 (S (NP (NN _PROT1_)) (ADVP (RB specifically)) (VP (VBD interacted) (PP (PP (IN with) (NP (DT the) (JJ general) (NN transcription) (NNS factors) (NP (NP (NN _PROT_)) (, ,) (NP (NN TBP)) (, ,) (CC and) (NP (NN _PROT2_))))) (CC but) (PP (RB not) (IN with) (NP (NN TFIIEalpha)))) (PP (IN in) (NP (DT the) (NN _PROT_) (JJ pull-down) (NNS assays))))))
-1 #(S1 (S (NP (NN _PROT1_)) (ADVP (RB specifically)) (VP (VBD interacted) (PP (PP (IN with) (NP (DT the) (JJ general) (NN transcription) (NNS factors) (NP (NP (NN _PROT_)) (, ,) (NP (NN TBP)) (, ,) (CC and) (NP (NN _PROT_))))) (CC but) (PP (RB not) (IN with) (NP (NN TFIIEalpha)))) (PP (IN in) (NP (DT the) (NN _PROT2_) (JJ pull-down) (NNS assays))))))
-1 #(S1 (S (NP (NN _PROT_)) (ADVP (RB specifically)) (VP (VBD interacted) (PP (PP (IN with) (NP (DT the) (JJ general) (NN transcription) (NNS factors) (NP (NP (NN _PROT1_)) (, ,) (NP (NN TBP)) (, ,) (CC and) (NP (NN _PROT2_))))) (CC but) (PP (RB not) (IN with) (NP (NN TFIIEalpha)))) (PP (IN in) (NP (DT the) (NN _PROT_) (JJ pull-down) (NNS assays))))))
-1 #(S1 (S (NP (NN _PROT_)) (ADVP (RB specifically)) (VP (VBD interacted) (PP (PP (IN with) (NP (DT the) (JJ general) (NN transcription) (NNS factors) (NP (NP (NN _PROT1_)) (, ,) (NP (NN TBP)) (, ,) (CC and) (NP (NN _PROT_))))) (CC but) (PP (RB not) (IN with) (NP (NN TFIIEalpha)))) (PP (IN in) (NP (DT the) (NN _PROT2_) (JJ pull-down) (NNS assays))))))
-1 #(S1 (S (NP (NN _PROT_)) (ADVP (RB specifically)) (VP (VBD interacted) (PP (PP (IN with) (NP (DT the) (JJ general) (NN transcription) (NNS factors) (NP (NP (NN _PROT_)) (, ,) (NP (NN TBP)) (, ,) (CC and) (NP (NN _PROT1_))))) (CC but) (PP (RB not) (IN with) (NP (NN TFIIEalpha)))) (PP (IN in) (NP (DT the) (NN _PROT2_) (JJ pull-down) (NNS assays))))))
-1 #(S1 (S (NP (NP (NN TBP)) (CC and) (NP (NN _PROT1_))) (, ,) (ADVP (RB however)) (, ,) (VP (VBD were) (RB not) (ADJP (JJ able) (S (VP (TO to) (VP (VB interact) (PP (IN with) (NP (NN _PROT2_))))))))))
-1 #(S1 (S (ADVP (RB Accordingly)) (, ,) (NP (NN _PROT1_)) (VP (VBN coactivated) (NP (NP (DT the) (JJ 9-cis-RA-induced) (NNS transactivations)) (PP (IN of) (NP (NN RXR)))) (, ,) (PP (IN in) (NN contrast) (TO to) (NP (NP (DT the) (JJ inhibitory) (NNS actions)) (PP (IN of) (NP (NN _PROT2_))))))))
-1 #(S1 (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NN coexpression)) (PP (IN of) (NP (NP (NN _PROT1_)) (CONJP (CC but) (RB not)) (NP (NN _PROT2_))))) (ADVP (RB further)) (VP (VBD stimulated) (NP (NP (DT the) (JJ Bcl3-mediated) (NN enhancement)) (PP (IN of) (NP (NP (DT the) (JJ 9-cis-RA-induced) (NNS transactivations)) (PP (IN of) (NP (NN RXR)))))))))
